Merck’s 11% Drop: A Few Quick Points 2-4-25
Podcast: Becker Private Equity & Business PodcastPublished On: Tue Feb 04 2025
Description: In this episode, Scott Becker breaks down Merck’s 11% stock decline, discussing its strong 2024 performance, concerns over slower growth in 2025, a weak drug pipeline, and upcoming patent expirations.
The note was deleted
The note was saved
Your message was sent